| Dr Robert B Taylor Iii, MD | |
|
3575 Pecos Mcleod, Las Vegas, NV 89121-3803 | |
| (702) 731-2088 | |
| (702) 734-7836 |
| Full Name | Dr Robert B Taylor Iii |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 34 Years |
| Location | 3575 Pecos Mcleod, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154374577 | NPI | - | NPPES |
| 1154374577 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 7161 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shepherd Eye Center Ltd | 9234125907 | 37 |
News Archive
Ben-Gurion University of the Negev researcher Alberto Bilenca, Ph.D., has been awarded a prestigious grant from the Bill & Melinda Gates Foundation to develop the a fast, low-cost device to accuracy diagnose malaria without the need for blood collection in field settings.
Bacteria inhabited our planet for more than 4 billion years before humans showed up, and they'll probably outlive us by as many eons more. That suggests they may have something to teach us.
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.
Intellikine, Inc. has initiated a Phase I clinical trial for its targeted anticancer drug INK128, a novel orally-available small molecule inhibitor of both the TORC1 and TORC2 complexes, key components of the PI3K/mTOR signaling pathway.
House Speaker John Boehner, R-Ohio, urged his fellow Republicans to "play offense" on the issue while their Democratic counterparts plan to keep the heat on.
› Verified 2 days ago
| Entity Name | Shepherd Eye Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487604054 PECOS PAC ID: 9234125907 Enrollment ID: O20040420001820 |
News Archive
Ben-Gurion University of the Negev researcher Alberto Bilenca, Ph.D., has been awarded a prestigious grant from the Bill & Melinda Gates Foundation to develop the a fast, low-cost device to accuracy diagnose malaria without the need for blood collection in field settings.
Bacteria inhabited our planet for more than 4 billion years before humans showed up, and they'll probably outlive us by as many eons more. That suggests they may have something to teach us.
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.
Intellikine, Inc. has initiated a Phase I clinical trial for its targeted anticancer drug INK128, a novel orally-available small molecule inhibitor of both the TORC1 and TORC2 complexes, key components of the PI3K/mTOR signaling pathway.
House Speaker John Boehner, R-Ohio, urged his fellow Republicans to "play offense" on the issue while their Democratic counterparts plan to keep the heat on.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert B Taylor Iii, MD 3575 Pecos Mcleod, Las Vegas, NV 89121-3803 Ph: (702) 202-4776 | Dr Robert B Taylor Iii, MD 3575 Pecos Mcleod, Las Vegas, NV 89121-3803 Ph: (702) 731-2088 |
News Archive
Ben-Gurion University of the Negev researcher Alberto Bilenca, Ph.D., has been awarded a prestigious grant from the Bill & Melinda Gates Foundation to develop the a fast, low-cost device to accuracy diagnose malaria without the need for blood collection in field settings.
Bacteria inhabited our planet for more than 4 billion years before humans showed up, and they'll probably outlive us by as many eons more. That suggests they may have something to teach us.
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.
Intellikine, Inc. has initiated a Phase I clinical trial for its targeted anticancer drug INK128, a novel orally-available small molecule inhibitor of both the TORC1 and TORC2 complexes, key components of the PI3K/mTOR signaling pathway.
House Speaker John Boehner, R-Ohio, urged his fellow Republicans to "play offense" on the issue while their Democratic counterparts plan to keep the heat on.
› Verified 2 days ago
Dr. Jason Craig Wickens, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 518, Las Vegas, NV 89144 Phone: 702-369-0200 Fax: 702-243-8383 | |
Dr. Surjeet Singh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 401, Las Vegas, NV 89106 Phone: 702-896-6043 Fax: 702-896-9591 | |
Peter Lloyd Hildebrand, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5005 | |
Dr. Brett D Brimhall, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6850 N Durango Dr, 110, Las Vegas, NV 89149 Phone: 702-263-2020 Fax: 702-396-0287 | |
Helga F Pizio, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5001 | |
Grace S Shin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6028 S Fort Apache Rd Ste 101, Las Vegas, NV 89148 Phone: 702-896-2020 Fax: 702-896-2025 | |
Dr. Jeffrey L. Hart, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5871 W. Craig Rd., Las Vegas, NV 89130 Phone: 702-724-2020 Fax: 702-724-2800 |